At the end of the latest market close, FibroGen, Inc. (FGEN) was valued at $41.94. In that particular session, Stock kicked-off at the price of $41.74 while reaching the peak value of $43.19 and lowest value recorded on the day was $41.42. The stock current value is $42.83.
FibroGen, Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $48.95 on 12/10/19, with the lowest value was $22.65 for the same time period, recorded on 03/19/20.
FibroGen, Inc. (FGEN) full year performance was 1.35%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, FibroGen, Inc. shares are logging -12.50% during the 52-week period from high price, and 89.09% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $22.65 and $48.95.
The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 604996 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the FibroGen, Inc. (FGEN) recorded performance in the market was -0.14%, having the revenues showcasing 26.64% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.85B, as it employees total of 531 workers.
Specialists analysis on FibroGen, Inc. (FGEN)
During the last month, 5 analysts gave the FibroGen, Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 5 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 37.42, with a change in the price was noted -0.54. In a similar fashion, FibroGen, Inc. posted a movement of -1.25% for the period of last 100 days, recording 747,755 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity. The total Debt to Equity ratio for FGEN is recording 0.14 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.11.
Trends and Technical analysis: FibroGen, Inc. (FGEN)
Raw Stochastic average of FibroGen, Inc. in the period of last 50 days is set at 91.38%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 91.38%. In the last 20 days, the company’s Stochastic %K was 88.79% and its Stochastic %D was recorded 90.31%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -0.14%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -6.57%, alongside a boost of 1.35% for the period of the last 12 months. The shares increased approximately by 8.21% in the 7-day charts and went down by 6.73% in the period of the last 30 days. Common stock shares were driven by 26.64% during last recorded quarter.